杂志简称：j immunother
中文译名：《免疫治疗杂志》
收录属性：scie（2024版）, 目次收录（维普）,英文期刊,
自引率：0.40%
投稿方向：医学、immunology 免疫学、medicine, research & experimental 医学、研究与实验、oncology 肿瘤学
SCI/E期刊基本信息
出版周期：年9期 地区：美国
中科院分区：4区
是否TOP：非TOP期刊
是否综述：非综述期刊
是否OA：非OA期刊
国际标准刊号：ISSN1524-9557；EISSN1537-4513
杂志语言：英语
出版国家：美国
杂志官网 联系方式
出版地址：LIPPINCOTT WILLIAMS & WILKINS,530 WALNUT ST,PHILADELPHIA,USA,PA,19106-3621
杂志邮箱：
投稿网址：https://www.editorialmanager.com/jit/
杂志官方网址：https://journals.lww.com/immunotherapy-journal/pages/default.aspx
出版商网址：http://www.lww.com/
杂志投稿要求
投稿须知【杂志社官方网站信息】
Instructions for Authors
SCOPE
Journal of Immunotherapy is a peer reviewed, multidisciplinary journal directed to an audience of immunotherapy and biological therapy physicians and researchers. The journal publishes original articles in the form of basic studies, clinical studies, and selected abstracts from scientific meetings and conferences.
Instructions for Authors (this page)
Reprint Ordering
Permissions Requests
Reprints
Ethical/Legal Considerations
A submitted manuscript must be an original contribution not previously published (except as an abstract or preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors, or the publisher. All manuscripts must be submitted on-line through the journal's Web site at http://editorialmanager.com/jit. See submission instructions below, under "On-line manuscript submission."
Patient anonymity and informed consent: It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Authors should mask patients' eyes and remove patients' names from figures unless they obtain written consent from the patients and submit written consent with the manuscript.
Copyright: All authors must sign a copy of the Journal's "Authorship Responsibility, Financial Disclosure, and Copyright Transfer" form and submit it at the time of manuscript submission.